Imatinib vs Irbesartan
Imatinib vs Irbesartan: Overview
This comparison examines the pharmacological differences between Imatinib and Irbesartan.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Irbesartan — 11-15 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Irbesartan — C25H28N6O.
Molecular Weight: Imatinib — 493.6030 g/mol; Irbesartan — 428.5320 g/mol.
Type: Imatinib — Small molecule; Irbesartan — Small molecule.